| 摘要 |
1. Cytotoxic pharmaceutical combination, characterized in that it comprises, - on the one hand, at least a first antibody possessing the capacity of selective recognition of a target antigen or antigens carried by cells to be destroyed, the said antibody being characteristic of a different animal species from that of the target cells, - on the other hand, at least one cytotoxic conjugate obtained by covalent bond coupling of the A chain of ricin with a second specific antibody of immunoglobins of the animal species to which the said first antibody or antibodies belong. |
